DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Kiechl S, Wittmann J, Giaccari A. et al.
Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus.
Nat Med 2013;
19: 358-363
We do not assume any responsibility for the contents of the web pages of other providers.